Rania Nasrallah

1.4k total citations
34 papers, 1.2k citations indexed

About

Rania Nasrallah is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, Rania Nasrallah has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 14 papers in Biochemistry and 12 papers in Molecular Biology. Recurrent topics in Rania Nasrallah's work include Eicosanoids and Hypertension Pharmacology (14 papers), Inflammatory mediators and NSAID effects (14 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Rania Nasrallah is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (14 papers), Inflammatory mediators and NSAID effects (14 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Rania Nasrallah collaborates with scholars based in Canada, United States and Brazil. Rania Nasrallah's co-authors include Richard Hébert, Rhian M. Touyz, Mona Sedeek, James W. Scholey, David Z.I. Cherney, Etienne Sochett, Maria G. Dekker, Cameron Slorach, Judith Miller and Timothy J. Bradley and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Rania Nasrallah

33 papers receiving 1.2k citations

Peers

Countries citing papers authored by Rania Nasrallah

Since Specialization

Citations

This map shows the geographic impact of Rania Nasrallah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rania Nasrallah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rania Nasrallah more than expected).

Fields of papers citing papers by Rania Nasrallah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rania Nasrallah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rania Nasrallah. The network helps show where Rania Nasrallah may publish in the future.

Co-authorship network of co-authors of Rania Nasrallah

This figure shows the co-authorship network connecting the top 25 collaborators of Rania Nasrallah. A scholar is included among the top collaborators of Rania Nasrallah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rania Nasrallah. Rania Nasrallah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Tolerability of a Novel Inhaled Thiol-Saccharide Mucolytic (Fexlamose, MUC-031) in Healthy Volunteers 2025 ·American Journal of Respiratory and Critical Care Medicine ·Jennifer A. Low, Ray W. Fuller, Irina Gitlin, Rania Nasrallah, William R. Thelin, Courtney Crim, John V. Fahy	0
2	Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy 2022 ·PLoS ONE ·Alex Gutsol, Paula Blanco, Taben M. Hale, Jean-François Thibodeau, Chet E. Holterman, Rania Nasrallah, José Wilson do Nascimento Corrêa, (unknown), Rhian M. Touyz, C. Kennedy, Dylan Burger, Richard Hébert, Kevin D. Burns	9
3	Prostaglandin E2 receptor EP1 (PGE2/EP1) deletion promotes glomerular podocyte and endothelial cell injury in hypertensive TTRhRen mice 2019 ·Laboratory Investigation ·Rania Nasrallah, Joseph Zimpelmann, Susan J. Robertson, (unknown), Jean-François Thibodeau, C. Kennedy, Alex Gutsol, Fengxia Xiao, Dylan Burger, Kevin D. Burns, Richard Hébert	9
4	Hyperfiltration in ubiquitin C-terminal hydrolase L1-deleted mice 2018 ·Clinical Science ·(unknown), Chet E. Holterman, Jean-François Thibodeau, Rania Nasrallah, (unknown), César H. Comin, Luciano da Fontoura Costa, Anthony Carter, Richard Hébert, Alex Gutsol, Greg O. Cron, Baptiste Lacoste, Douglas A. Gray, C. Kennedy	3
5	PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct 2017 ·Laboratory Investigation ·Rania Nasrallah, Joseph Zimpelmann, (unknown), (unknown), (unknown), Jean‐Claude Béïque, Jean-François Thibodeau, C. Kennedy, Kevin D. Burns, Richard Hébert	23
6	PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes 2016 ·Diabetologia ·(unknown), Rania Nasrallah, (unknown), Alex Gutsol, (unknown), (unknown), Kevin D. Burns, Richard Hébert	30
7	PGE2, Kidney Disease, and Cardiovascular Risk 2015 ·Journal of the American Society of Nephrology ·Rania Nasrallah, (unknown), Richard Hébert	81
8	Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors 2015 ·Laboratory Investigation ·Rania Nasrallah, (unknown), Joseph Zimpelmann, (unknown), Jean-François Thibodeau, Dylan Burger, Kevin D. Burns, C. Kennedy, Richard Hébert	13
9	PTGER1 Deletion Attenuates Renal Injury in Diabetic Mouse Models 2013 ·American Journal Of Pathology ·Jean-François Thibodeau, Rania Nasrallah, Anthony Carter, Ying He, Rhian M. Touyz, Richard Hébert, C. Kennedy	16
10	Cyclooxygenase-2 mediates induction of the renal stanniocalcin-1 gene by arginine vasopressin 2013 ·Molecular and Cellular Endocrinology ·Alice Law, Richard Hébert, Rania Nasrallah, Robert Langenbach, Chris K.C. Wong, Graham F. Wagner	1
11	NADPH Oxidases, Reactive Oxygen Species, and the Kidney 2013 ·Journal of the American Society of Nephrology ·Mona Sedeek, Rania Nasrallah, Rhian M. Touyz, Richard Hébert	387
12	Hypertonicity increases sodium transporters in cortical collecting duct cells independently of PGE2 2012 ·Biochemical and Biophysical Research Communications ·Rania Nasrallah, Geneviève Paris, Richard Hébert	3
13	Chronic COX Inhibition Reduces Diabetes-Induced Hyperfiltration, Proteinuria, and Renal Pathological Markers in 36-Week B6-Ins2<sup>Akita</sup> Mice 2009 ·American Journal of Nephrology ·Rania Nasrallah, (unknown), Richard Hébert	27
14	The PPARδ Ligand GW501516 Reduces Growth but Not Apoptosis in Mouse Inner Medullary Collecting Duct Cells 2009 ·PPAR Research ·(unknown), Rania Nasrallah, Richard Hébert	7
15	Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus 2008 ·American Journal of Physiology-Renal Physiology ·David Z.I. Cherney, James W. Scholey, Rania Nasrallah, Maria G. Dekker, Cameron Slorach, Timothy J. Bradley, Richard Hébert, Etienne Sochett, Judith Miller	36
16	The Effect of Cyclooxygenase-2 Inhibition on Renal Hemodynamic Function in Humans With Type 1 Diabetes 2007 ·Diabetes ·David Z.I. Cherney, Judith Miller, James W. Scholey, Timothy J. Bradley, Cameron Slorach, (unknown), Maria G. Dekker, Rania Nasrallah, Richard Hébert, Etienne Sochett	75
17	Renal prostaglandin E₂ receptor (EP) expression profile is altered in streptozotocin and B6-Ins2^Akita type I diabetic mice 2006 ·American Journal of Physiology-Renal Physiology ·Rania Nasrallah, Huaqi Xiong, Richard Hébert	24
18	Prostacyclin signaling in the kidney: implications for health and disease 2005 ·American Journal of Physiology-Renal Physiology ·Rania Nasrallah, Richard Hébert	73
19	Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells 2004 ·American Journal of Physiology-Renal Physiology ·Rania Nasrallah, Richard Hébert	14
20	Characterization of the PGI2/IP system in cultured rat mesangial cells 2004 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Rania Nasrallah, (unknown), James W. Scholey, Richard Hébert	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact